Fig. 2.
Use of patient derived hematopoietic stem cells, T cells and monocytes for ex vivo gene modification with lentiviral vectors and re-administration for gene correction and immune therapy purposes
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.